These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 26661515)

  • 1. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
    Whitman E; Barber A
    Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.
    Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
    J Leukoc Biol; 2014 Mar; 95(3):487-95. PubMed ID: 24168855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
    Rajasekaran K; Xiong V; Fong L; Gorski J; Malarkannan S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
    Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A
    J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 Influence mTOR to Modulate CD8
    Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
    Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
    [No Abstract]   [Full Text] [Related]  

  • 7. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2D induces Mcl-1 expression and mediates survival of CD8 memory T cell precursors via phosphatidylinositol 3-kinase.
    Wensveen FM; Lenartic M; Jelencic V; Lemmermann NA; ten Brinke A; Jonjic S; Polic B
    J Immunol; 2013 Aug; 191(3):1307-15. PubMed ID: 23804716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome.
    Boita M; Rolla G; Mallone R; Martinuzzi E; Heffler E; Circosta P; Elia AR; Cignetti A; Caillat-Zucman S; de Menthon M; Guida G
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S57-61. PubMed ID: 22640649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
    Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
    J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
    Kennedy PT; Gehring AJ; Nowbath A; Selden C; Quaglia A; Dhillon A; Dusheiko G; Bertoletti A
    J Viral Hepat; 2008 Dec; 15(12):901-9. PubMed ID: 19087227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells.
    Arnold CR; Pritz T; Brunner S; Knabb C; Salvenmoser W; Holzwarth B; Thedieck K; Grubeck-Loebenstein B
    Exp Gerontol; 2014 Jun; 54():75-83. PubMed ID: 24468331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
    Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
    Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of RLR-Mediated Antiviral Responses of Human Dendritic Cells by mTOR.
    Fekete T; Ágics B; Bencze D; Bene K; Szántó A; Tarr T; Veréb Z; Bácsi A; Pázmándi K
    Front Immunol; 2020; 11():572960. PubMed ID: 33013932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
    Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
    Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.
    Sabins NC; Chornoguz O; Leander K; Kaplan F; Carter R; Kinder M; Bachman K; Verona R; Shen S; Bhargava V; Santulli-Marotto S
    J Immunol; 2017 Dec; 199(12):4091-4102. PubMed ID: 29127145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
    Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
    J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.